Vascular risk calculators: Essential but flawed clinical tools?

Circulation

Volumn 127, Issue 19, 2013, Pages 1929-1931

  Jackson, Rod ^a   Kerr, Andrew ^b   Wells, Sue ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

^b MIDDLEMORE HOSPITAL   (New Zealand)

Author keywords

cardiovascular diseases; cardiovascular events; decision support techniques; Editorials; prediction; risk factors

Indexed keywords

LOW DENSITY LIPOPROTEIN CHOLESTEROL;

CALCULATION; CALIBRATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT TOOL; DECISION SUPPORT SYSTEM; EVIDENCE BASED MEDICINE; HUMAN; MEDICAL LITERATURE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; SCORING SYSTEM;

CARDIOVASCULAR DISEASES; CARDIOVASCULAR EVENTS; DECISION SUPPORT TECHNIQUES; EDITORIALS; PREDICTION; RISK FACTORS;

CARDIOVASCULAR DISEASES; HUMANS; RESEARCH DESIGN;

EID: 84877878563     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.113.002650     Document Type: Review

References (22)

1. Mihaylova B, Emberson J, Blackwell L, Keech A, Simes J, Barnes EH, Voysey M, Gray A, Collins R, Baigent C. The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet. 2012;380:581-590.
2. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profles. Am Heart J. 1991;121(pt 2):293-298.
3. Hippisley-Cox J, Coupland C, Vinogradova Y, Robson J, Minhas R, Sheikh A, Brindle P. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ. 2008;336:1475-1482.
4. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, De Bacquer D, Ducimetière P, Jousilahti P, Keil U, Njølstad I, Oganov RG, Thomsen T, Tunstall-Pedoe H, Tverdal A, Wedel H, Whincup P, Wilhelmsen L, Graham IM; SCORE Project Group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J. 2003;24:987-1003.
5. Montgomery AA, Fahey T, MacKintosh C, Sharp DJ, Peters TJ. Estimation of cardiovascular risk in hypertensive patients in primary care. Br J Gen Pract. 2000;50:127-128.
6. McManus RJ, Mant J, Meulendijks CF, Salter RA, Pattison HM, Roalfe AK, Hobbs FD. Comparison of estimates and calculations of risk of coronary heart disease by doctors and nurses using different calculation tools in general practice: cross sectional study. BMJ. 2002;324:459-464.
7. New Zealand Guidelines Group. The Assessment and Management of Cardiovascular Risk. Wellington, New Zealand; New Zealand Guidelines Group; 2003. http://www.nzgg.org.nz/guidelines/0035/CVD-Risk-Full.pdf. Accessed April 26, 2013.
8. Perk J, De Backer G, Gohlke H, Graham I, Reiner Z, Verschuren M, Albus C, Benlian P, Boysen G, Cifkova R, Deaton C, Ebrahim S, Fisher M, Germano G, Hobbs R, Hoes A, Karadeniz S, Mezzani A, Prescott E, Ryden L, Scherer M, Syvanne M, Scholte op Reimer WJ, Vrints C, Wood D, Zamorano JL, Zannad F. European guidelines on cardiovascular disease prevention in clinical practice (version 2012). Eur Heart J. 2012;33:1635-1701.
9. Allan GM, Nouri F, Korownyk C, Kolber MR, Vandermeer B, McCormack J. Agreement among cardiovascular disease risk calculators. Circulation. 2013;127:1948-1956.
10. Kerr AJ, Broad J, Wells S, Riddell T, Jackson R. Should the frst priority in cardiovascular risk management be those with prior cardiovascular disease? Heart. 2009;95:125-129.
11. Liu J, Hong Y, D'Agostino RB Sr, Wu Z, Wang W, Sun J, Wilson PW, Kannel WB, Zhao D. Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study. JAMA. 2004;291:2591-2599.
12. Barzi F, Patel A, Gu D, Sritara P, Lam TH, Rodgers A, Woodward M. Cardiovascular risk prediction tools for populations in Asia. J Epidemiol Community Health. 2007;61:115-121.
13. Ganz PA. What outcomes matter to patients: a physician-researcher point of view. Med Care. 2002;40(suppl):III11-III19.
14. Huber M, Knottnerus JA, Green L, van der Horst H, Jadad AR, Kromhout D, Leonard B, Lorig K, Loureiro MI, van der Meer JW, Schnabel P, Smith R, van Weel C, Smid H. How should we defne health? BMJ. 2011;343:d4163.
15. Levi F, Chatenoud L, Bertuccio P, Lucchini F, Negri E, La Vecchia C. Mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world: an update. Eur J Cardiovasc Prev Rehabil. 2009;16:333-350.
16. Jackson R. Cardiovascular risk prediction: are we there yet? Heart. 2008;94:1-3
17. Emerging Risk Factors Collaboration. C-reactive protein, fbrinogen, and cardiovascular disease prediction. N Engl J Med. 2012;367:1310-1320.
18. Jackson R, Lawes CM, Bennett DA, Milne RJ, Rodgers A. Treatment with drugs to lower blood pressure and blood cholesterol based on an individual's absolute cardiovascular risk. Lancet. 2005;365:434-441.
19. Kawamoto K, Houlihan CA, Balas EA, Lobach DF. Improving clinical practice using clinical decision support systems: a systematic review of trials to identify features critical to success. BMJ. 2005;330:765.
20. Soureti A, Hurling R, Murray P, van Mechelen W, Cobain M. Evaluation of a cardiovascular disease risk assessment tool for the promotion of healthier lifestyles. Eur J Cardiovasc Prev Rehabil. 2010;17:519-523.
21. Wells S, Kerr A, Eadie S, Wiltshire C, Jackson R. "Your Heart Forecast": a new approach for describing and communicating cardiovascular risk? Heart. 2010;96:708-713.
22. Heart Foundation. Your heart forecast. http://www.knowyournumbers. co.nz/heart-age-forecast.aspx.